F. Casanovas

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

P. Sáiz, J. Nacher, E. Pomarol-Clotet, 2022, Schizophrenia.

Gene co-expression architecture in peripheral blood in a cohort of remitted first-episode schizophrenia patients

P. Sáiz, J. Nacher, E. Pomarol-Clotet, 2022, Schizophrenia.

Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study

A. Mané, D. Bergé, V. Pérez-Solà, 2022, Scientific reports.

Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis

L. Blanco-Hinojo, A. Mané, D. Bergé, 2023, European Neuropsychopharmacology.

The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

J. Bobes, J. Castro-Fornieles, E. de la Serna, 2020, Psychopharmacology.

Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug–na ïve first-episode psychosis

L. Blanco-Hinojo, A. Mané, D. Bergé, 2023, European Neuropsychopharmacology.

The polygenic basis of relapse after a first episode of schizophrenia

P. Sáiz, E. Pomarol-Clotet, M. Parellada, 2023, European Neuropsychopharmacology.

Substance use Specificities in Women with Psychosis: A Critical Review

F. Fonseca, A. Mané, F. Casanovas, 2022, Current neuropharmacology.